Jefferies Upgrades Coach (COH) to Buy
Tweet Send to a Friend
Get Alerts COH Hot Sheet
Price: $59.23 +1.46%
Rating Summary:
14 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
14 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade COH Now!
Jefferies upgraded Coach (NYSE: COH) from Hold to Buy with a price target of $60.00.
The firm said, "We believe the recent market pullback has created a compelling buying opportunity with COH shares. We cannot ignore the powerful brand here with sales momentum and a global growth story consistent with our broader industry thesis to buy global growth retailers. While valuation kept us on the sidelines before, we now view valuation as attractive and current risk/reward as compelling."
For more ratings news on Coach click here and for the rating history of Coach click here.
Shares of Coach closed at $47.20 yesterday, with a 52 week range of $35.06-$69.20.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm said, "We believe the recent market pullback has created a compelling buying opportunity with COH shares. We cannot ignore the powerful brand here with sales momentum and a global growth story consistent with our broader industry thesis to buy global growth retailers. While valuation kept us on the sidelines before, we now view valuation as attractive and current risk/reward as compelling."
For more ratings news on Coach click here and for the rating history of Coach click here.
Shares of Coach closed at $47.20 yesterday, with a 52 week range of $35.06-$69.20.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Leerink Swann Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
- UPDATE: BofA/Merrill Lynch Upgrades J. C. Penney (JCP) to Neutral
- UPDATE: Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesRelated Entities
Jefferies & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
